SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
124 hedge funds and large institutions have $3.15B invested in SpringWorks Therapeutics in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 56 increasing their positions, 16 reducing their positions, and 7 closing their positions.
457% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 7
250% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 16
76% more capital invested
Capital invested by funds: $1.79B → $3.15B (+$1.36B)
35% more funds holding
Funds holding: 92 → 124 (+32)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
1.83% more ownership
Funds ownership: 87.13% → 88.96% (+1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$116M |
| 2 |
BlackRock
New York
|
+$58.7M |
| 3 |
PA
Perceptive Advisors
New York
|
+$44.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.9M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$32.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$132M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.3M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$8.72M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.96M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$5.44M |
SWTX Hedge Fund Activity: Q4 2020 in Review
124 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q4 2020, worth a combined $3.15B — up 76% from $1.79B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new SWTX positions and 7 closed out — a net gain of 32 holders — while 56 added to existing stakes and 16 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $116M. The largest seller was BVF Inc, cutting an estimated $132M.
- 124 institutional investors held SpringWorks Therapeutics (SWTX) as of Q4 2020, up from 92 in Q3 2020.
- Funds reported $3.15B of SpringWorks Therapeutics stock for Q4 2020, up 76% quarter-over-quarter.
- 39 funds opened new SpringWorks Therapeutics positions in Q4 2020 and 7 closed out, a net change of +32 holders.
- The largest SpringWorks Therapeutics buyer in Q4 2020 was Fidelity Investments, an estimated $116M added.
- The largest SpringWorks Therapeutics seller in Q4 2020 was BVF Inc, an estimated $132M sold.
Based on aggregated 13F filings for Q4 2020.